EVALUATION OF TREATMENT RESULTS APPLIED IN SUDDEN HEARING LOSSES TREATED IN OUR CLINIC

Purpose: Sudden sensorineural hearing loss (SSNHL) is sensorineural hearing loss over 30 dB, which develops abruptly in less than three days, affecting three or more frequencies. Prognostic factors affecting the treatment results and treatment outcomes of patients with SSNHL were examined in this study. Material and method: Between 2011 and 2014, 65 cases included in 68 ear studies. All patients were given steroids, vasodilator drugs (betahistine) and vitamin B. In the treatment of patients who did not show significant audiological improvement in 5 days, in the event that they gave consent, 0.5-0.7 cc 250 mg methylprednisolone of intratympanic was added per day in addition to systemic steroid therapy and salvage treatment was performed. Anamnesis details and clinical findings of patients, audiological configurations and degrees of hearing loss, treatment start times, vertigo and tinnitus relationship with the SSNHL and the effects of these factors on prognosis were examined in this study. Results: In this study, 31 of the cases were male and 34 were female. The age range was between 12-75 (average 44.2). It was observed that twelve (17.6%) cases had mild, 23 (33.8%) had moderate, 24 (35.3%) had advanced and 9 (13.2%) had very advanced SSNHL. In patients treated early, statistically significant results were obtained in terms of positive response to treatment (p

KLİNİĞİMİZDE TEDAVİ GÖREN ANİ İŞİTME KAYIPLARINDA UYGULANAN TEDAVİ SONUÇLARININ DEĞERLENDİRİLMESİ

Amaç: Ani sensörinöral işitme kaybı (SSNHL), üç günden daha kısa sürede aniden gelişen ve üç veya daha fazla frekansı etkileyen 30 dB üzerindeki sensörinöral işitme kaybıdır. Bu çalışmada SSNHL'li hastaların tedavi sonuçları ve tedavi sonuçlarını etkileyen prognostik faktörler incelenmiştir. Gereç ve yöntem: 2011-2014 yılları arasında 65 hasta ve 68 kulak çalışmaya dahil edildi. Tüm hastalara steroid, vazodilatör ilaçlar (betahistin) ve B vitamini verildi. 5 gün içerisinde odyolojik olarak belirgin iyileşme göstermeyen hastaların tedavisine onam vermeleri halinde sistemik steroid tedavisinin yanına gün aşırı intratimpanik 0.5-0.7cc 250 mg metilprednizolon eklenerek salvage tedavisi uygulandı. Klinik bulguları, odyolojik konfigürasyonları ve işitme kayıplarının dereceleri , tedavi başlama süreleri, vertigo ve tinnitusla SSNHL ilişkisi ve bu faktörlerin prognoz üzerine olan etkileri bu çalışmada incelendi. Bulgular: Bu çalışmada olguların 31'si erkek 34'i bayan idi. Yaş aralığı 12-75 arasında idi (ortalama 44.2). On iki (%17.6) olguda hafif, 23 (%33.8) olguda orta, 24 (%35.3) olguda ileri ve 9 (%13.2) olguda çok ileri SSNHL olduğu görüldü. Erken tedavi verilmiş olgularda, tedaviye olumlu yanıt açısından istatistiksel olarak anlamlı sonuçlar alındı (p

Kaynakça

1. Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA, et al. Clinical Practice Guideline: Sudden Hearing Loss (Update). Otolaryngol Head Neck Surg. 2019;161(1_suppl):S1-S45.

2. Hughes GB, Freedman MA, Haberkamp TJ, Guay ME. Sudden sensorineural hearing loss. Otolaryngol Clin North Am. 1996;29(3):393-405.

3. Marx M, Younes E, Chandrasekhar SS, Ito J, Plontke S, O'Leary S, et al. International consensus (ICON) on treatment of sudden sensorineural hearing loss. Eur Ann Otorhinolaryngol Head Neck Dis. 2018;135(1S):S23-S8.

4. Eisenman D, Arts HA. Effectiveness of treatment for sudden sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2000;126(9):1161-4.

5. Leong AC, Fairley JW, Padgham ND. Sudden hearing loss. Clin Otolaryngol. 2007;32(5):391-4.

6. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: I. A systematic review. Arch Otolaryngol Head Neck Surg. 2007;133(6):573-81.

7. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Arch Otolaryngol. 1980;106(12):772-6.

8. Harcourt JP, Lambert A, Wong PY, Patel M, Agarwal K, Golding JF, et al. Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Meniere's Disease. Otol Neurotol. 2019;40(4):491-6.

9. Haynes DS, O'Malley M, Cohen S, Watford K, Labadie RF. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope. 2007;117(1):3-15.

10. Booth JB. Sudden and fluctuant sensorineural hearing loss. In: Kerr AG, editor. Scott Brown's otolaryngology. 6th. ed. London: Butterworths-Heinemann; 1997;3(17):1-82.

11. Gok U, Kapusuz Z, Sapmaz E, Yildiz M. Ani isitme kaybinda saf ses odyogram tipleri ile prognoz arasindaki iliski. Firat Tip Dergisi. 2007;12(1):13-6.

12. Suzuki H, Furukawa M, Kumagai M, Takahashi E, Matsuura K, Katori Y, et al. Defibrinogenation therapy for idiopathic sudden sensorineural hearing loss in comparison with high-dose steroid therapy. Acta Otolaryngol. 2003;123(1):46-50.

13. Westerlaken BO, de Kleine E, van der Laan B, Albers F. The treatment of idiopathic sudden sensorineural hearing loss using pulse therapy: a prospective, randomized, double-blind clinical trial. Laryngoscope. 2007;117(4):684-90.

14. Grandis JR, Hirsch BE, Wagener MM. Treatment of idiopathic sudden sensorineural hearing loss. Am J Otol. 1993;14(2):183-5.

15. Slattery WH, Fisher LM, Iqbal Z, Liu N. Oral steroid regimens for idiopathic sudden sensorineural hearing loss. Otolaryngol Head Neck Surg. 2005;132(1):5-10.

16. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical Practice Guideline:Sudden Hearing Loss. Otolaryngology?Head and Neck Surgery. 2012;146(3_suppl):S1-S35.

17. Kordis S, Battelino S. The Role of High Dose Intratympanic Dexamethasone as Salvage Therapy for Idiopathic Sudden Sensorineural Hearing Loss. J Int Adv Otol. 2017;13(3):318-21.

18. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1977;86(4 Pt 1):463-80.

19. Byl FM. Seventy-six cases of presumed sudden hearing loss occurring in 1973: prognosis and incidence. Laryngoscope. 1977;87(5 Pt 1):817-25.

20. Alexander TH, Harris JP. Incidence of sudden sensorineural hearing loss. Otol Neurotol. 2013;34(9):1586-9.

21. Ryu IY, Park SH, Park EB, Kim HJ, Kim SH, Yeo SG. Factors Prognostic of Season-Associated Sudden Sensorineural Hearing Loss: A Retrospective Observational Study. J Audiol Otol. 2017;21(1):44-8.

22. Mamak A, Yilmaz S, Cansiz H, Inci E, Guclu E, Derekoylu L. A study of prognostic factors in sudden hearing loss. Ear Nose Throat J. 2005;84(10):641-4.

23. Shaia FT, Sheehy JL. Sudden sensori-neural hearing impairment: a report of 1,220 cases. Laryngoscope. 1976;86(3):389-98.

24. Çelik O, Gök Ü, Yalçın Ş, Yanık H, Hançer A, Kaygusuz S, et al. Ani işitme kayıplı hastalarımızın retrospektif analizi. Kulak Burun Boğaz İhtisas Dergisi. 1997;4:39-42.

25. Niu X, Zhang Y, Zhang Q, Xu X, Han P, Cheng Y, et al. The relationship between hearing loss and vestibular dysfunction in patients with sudden sensorineural hearing loss. Acta Otolaryngol. 2016;136(3):225-31.

26. Li FJ, Wang DY, Wang HY, Wang L, Yang FB, Lan L, et al. Clinical Study on 136 Children with Sudden Sensorineural Hearing Loss. Chin Med J (Engl). 2016;129(8):946-52.

27. Toroslu T, Erdogan H, Caglar O, Guclu O, Derekoy FS. Comparison of Different Treatment Methods for Idiopathic Sudden Sensorineural Hearing Loss. Turk Arch Otorhinolaryngol. 2018;56(4):226-32.

28. Gordin A, Goldenberg D, Golz A, Netzer A, Joachims HZ. Magnesium: a new therapy for idiopathic sudden sensorineural hearing loss. Otol Neurotol. 2002;23(4):447-51.

29. Michiba T, Kitahara T, Hikita-Watanabe N, Fukushima M, Ozono Y, Imai R, et al. Residual tinnitus after the medical treatment of sudden deafness. Auris Nasus Larynx. 2013;40(2):162-6.

Kaynak Göster